Passage Bio, Inc. Share Price
NASDAQ: PASG | Micro CapPassage Bio, Inc. Stock Performance
Open $4.42 | Prev. Close $4.47 | Circuit Range N/A |
Day Range $4.42 - $4.52 | Year Range $3.33 - $19.81 | Volume 836 |
Average Traded $4.49 |
Passage Bio, Inc. Share Price Today
As of 29 August 2026, Passage Bio, Inc.'s share price is $4.56. The stock opened at $4.42, compared to its previous close of $4.47. During today's trading session, Passage Bio, Inc.'s share price traded between $4.42 and $4.52, with an average price of $4.47. Over the past 52 weeks, the stock has recorded a high of $19.81 and a low of $3.33. In terms of performance, Passage Bio, Inc.'s share price has declined by 49.78% over the last six months and is down 34.01% on a year-on-year basis.
Passage Bio, Inc. Share Price Chart
Passage Bio, Inc. Stock Fundamentals & Key Indicators
Market Cap $14.47M | PE Ratio (TTM) -0.32 | Dividend Yield N/A |
EPS (TTM) $-14.35 | Revenue (TTM) N/A | Return On Equity (TTM) -242.72% |
Profit Margin N/A | Debt to Equity 1.23 | Quarterly Earnings Growth YoY 59.93% |
Passage Bio, Inc. Quarterly Profit & Loss
All figures in USD
Passage Bio, Inc. Annual Profit & Loss
All figures in USD
About Passage Bio, Inc.
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; PBFT02, a functional granulin (GRN) and gene encoding progranulin (PGRN) for the treatment of FTD caused by progranulin deficiency; and PBKR03, a functional GALC gene encoding the hydrolytic enzyme galactosylceramidase for infantile Krabbe disease. The company develops PBML04 for the treatment of metachromatic leukodystrophy; PBAL05 for the treatment of amyotrophic lateral sclerosis; and other program for huntington's disease. It has a strategic research collaboration with the Trustees of the University of Pennsylvania's Gene Therapy Program; and collaboration agreement, and a development services and clinical supply agreement with Catalent Maryland, Inc. The company was incorporated in 2017 and is based in Philadelphia, Pennsylvania.
Passage Bio, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $4.68 | $4.47 | +0.00% |
Jul 2026 | $4.92 | $4.47 | -8.21% |
Jun 2026 | $5.80 | $4.87 | -14.56% |
May 2026 | $5.00 | $5.70 | +14.23% |
Apr 2026 | $7.64 | $4.99 | -31.55% |
Mar 2026 | $8.63 | $7.29 | -19.71% |
Feb 2026 | $12.18 | $9.08 | -20.97% |
Jan 2026 | $11.82 | $11.49 | -1.37% |
Dec 2025 | $8.03 | $11.65 | +34.60% |
Nov 2025 | $7.72 | $8.65 | +14.26% |
Oct 2025 | $8.09 | $7.58 | -5.77% |
Sep 2025 | $7.01 | $8.04 | +16.34% |
PASG Share Price FAQs
What is Passage Bio, Inc. share price today?
What is the 52 week high and 52 week low of Passage Bio, Inc. stock?
What is PASG's market capitalisation today?
What is PASG's net income for the last quarter?
What is the 5 year returns of PASG?
What is the high & low stock price of PASG today?
Can I buy PASG shares in India?